Advertisement
Screener

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Profit Breakdown

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Profit Breakdown

  • 2026-06-27: Services $256.28M; Products $107.09M.
  • 2025-06-28: Services $255.96M; Products $101.11M.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2008-12-27 to 2026-06-27
Data captured

Profit by product

Gross margin: each quarter (3 month)

Quarter endServicesProducts
2026-06-27$256.28M
derived
$107.09M
derived
2025-06-28$255.96M
derived
$101.11M
derived

Operating income: each quarter (3 month)

Quarter endReportable Segment, Aggregation before Other OperatingDiscovery and Safety AssessmentManufacturing SupportResearch Models and Services
2026-06-27$226.28M$124.40M$65.61M$36.28M
2025-06-28$170.63M$122.78M$12.06M$35.79M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71